Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells

Journal of Molecular and Cellular Cardiology

Volumn 74, Issue , 2014, Pages 139-150

  Wang, Xiaohong ^a   Huang, Wei ^a   Liu, Guansheng ^a   Cai, Wenfeng ^a   Millard, Ronald W ^a   Wang, Yigang ^a   Chang, Jiang ^b   Peng, Tianqing ^c   Fan, Guo Chang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Texas A and M Health Sciences Center   (United States)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Cardiomyocytes; Exosomes; MiR 320; Myocardial angiogenesis; Type 2 diabetes

Indexed keywords

HEAT SHOCK PROTEIN 20; MICRORNA; MICRORNA 126; MICRORNA 320; UNCLASSIFIED DRUG; 3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; ANILINE DERIVATIVE; BENZYLIDENE DERIVATIVE; BIOLOGICAL MARKER; ETS2 PROTEIN, RAT; SOMATOMEDIN C; TRANSCRIPTION FACTOR ETS 2;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL VACUOLE; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EXOSOME; HEART MUSCLE CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL; CELL MOTION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANILINE COMPOUNDS; ANIMALS; BENZYLIDENE COMPOUNDS; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; EXOSOMES; GENE EXPRESSION REGULATION; HSP20 HEAT-SHOCK PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICRORNAS; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-2; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84904768520     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.05.001     Document Type: Article

References (30)

1. Raslova K. An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog. Vasc Health Risk Manag 2010, 6:399-410.
2. Nakagami H., Kaneda Y., Ogihara T., Morishita R. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Curr Diabetes Rev 2005, 1:59-63.
3. Cohen G., Riahi Y., Alpert E., Gruzman A., Sasson S. The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Biochem 2007, 113:259-267.
4. Costa P.Z., Soares R. Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci 2013, 92:1037-1045.
5. Heather L.C., Clarke K. Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol 2011, 50:598-605.
6. Yan J., Tie G., Park B., Yan Y., Nowicki P.T., Messina L.M. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J Vasc Surg 2009, 50:1412-1422.
7. Rivard A., Silver M., Chen D., Kearney M., Magner M., Annex B., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999, 154:355-363.
8. Simons M. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?. J Am Coll Cardiol 2005, 46:835-837.
9. Hsieh P.C., Davis M.E., Lisowski L.K., Lee R.T. Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol 2006, 68:51-66.
10. Schorey J.S., Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9(6):871-881.
11. Vlassov A.V., Magdaleno S., Setterquist R., Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820, 2012:940-948.
12. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013, 200:373-383.
13. Ribeiro M.F., Zhu H., Millard R.W., Fan G.C. Exosomes function in pro- and anti-angiogenesis. Curr Angiogenesis 2013, 2:54-59.
14. Zhang X., Wang X., Zhu H., Kranias E.G., Tang Y., Peng T., et al. Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2. PLoS ONE 2012, 7(3):e32765.
15. Waldenström A., Gennebäck N., Hellman U., Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE 2012, 7(4):e34653.
16. Malik Z.A., Kott K.S., Poe A.J., Kuo T., Chen L., Ferrara K.W., et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 2013, 304:H954-H965.
17. Wang X.H., Qian R.Z., Zhang W., Chen S.F., Jin H.M., Hu R.M. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2009, 36:181-188.
18. Caporali A., Meloni M., Völlenkle C., Bonci D., Sala-Newby G.B., Addis R., et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011, 123:282-291.
19. Mocharla P., Briand S., Giannotti G., Dörries C., Jakob P., Paneni F., et al. AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013, 121:226-236.
20. Feng B., Chakrabarti S. miR-320 regulates glucose-induced gene expression in diabetes. ISRN Endocrinol 2012, 1-6. 10.5402/2012/549875.
21. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010, 39:133-144.
22. Wang X., Zingarelli B., O'Connor M., Zhang P., Adeyemo A., Kranias E.G., et al. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J Mol Cell Cardiol 2009, 47:382-390.
23. Barbieri S.S., Weksler B.B. Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. FASEB J 2007, 21:1831-1843.
24. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010, 285:17442-17452.
25. Malik Z.A., Kott K.S., Poe A.J., Kuo T., Chen L., Ferrara K.W., et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 2013, 304:H954-H965.
26. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
27. Ren X.P., Wu J., Wang X., Sartor M.A., Qian J., Jones K., et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119:2357-2366.
28. Portha B., Giroix M.H., Tourrel-Cuzin C., Le-Stunff H., Movassat J. The GK rat: a prototype for the study of non-overweight type 2 diabetes. Methods Mol Biol 2012, 933:125-159.
29. Chalmin F., Ladoire S., Mignot G., Vincent J., Bruchard M., Remy-Martin J.P., et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010, 120:457-471.
30. Bronisz A., Godlewski J., Wallace J.A., Merchant A.S., Nowicki M.O., Mathsyaraja H., et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 2011, 14:159-167.